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a  b  s  t  r  a  c  t
Fabry disease is an inherited, X-linked lysosomal storage disorder caused by deﬁciency of
the enzyme alpha galactosidase A (alpha-GLA A), which leads to glycosphingolipid accu-
mulation, mainly globotriaosylceramide, in tissues. Disease prevalence and the index of
suspicion are both low, which tends to result in delayed diagnosis and treatment.
We  present the case of a male Fabry disease patient who manifested no angiokeratoma
lesions but presented multiple parapelvic cysts and renal failure. The genetic study revealed
an  alpha-GLA A gene mutation that had not been recorded in the mutations registry. The
de  novo mutation was not found in his relatives and it was not transmitted to his offspring.
The large number and peculiar appearance of the parapelvic cysts led to the diagnosis.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Múltiples  quistes  parapiélicos  en  la  enfermedad  de  Fabry
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r  e  s  u  m  e  n
La enfermedad de Fabry es una enfermedad de depósito lisosomal de carácter hereditario,
ligada al cromosoma X, causado por el déﬁcit de la enzima alfa-galactosidasa A (alfa-GLA
A),  lo que conduce a la acumulación de glicoesﬁngolípidos, principalmente globotriaosil-
Mutación de novo ceramida, en los tejidos. Es una enfermedad poco prevalente, y con muy bajo índice de
, generalmente, existe un retraso en el diagnóstico y en el tratamiento.sospecha, por lo quePresentamos un caso de un paciente varón afecto de la enfermedad de Fabry, que pre-
sentaba múltiples quistes parapiélicos e insuﬁciencia renal, sin presentar angioqueratomas.
El  estudio genético mostró una mutación en el gen de alfa-GLA A que no ha sido descrita
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previamente en el registro de mutaciones, y de novo, ya que no se encontró en otros famil-
iares, además que no fue trasmitida a la descendencia. La presencia de múltiples quistes
parapiélicos y su peculiar aspecto fue lo que hizo sospechar el diagnóstico de la enfermedad.
©  2016 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Fig. 1 – Abdominal ultrasound, in a longitudinal oblique
view of the left kidney, showing corticomedullary
hyperechogenicity (white arrows) and parapelvic cysts
tion (deletion of a single nucleotide) in exon 7 of the alpha-GLA
A gene. The patient’s mother and sister were investigated and
found to be negative for this mutation. The patient’s remaining
siblings were not available for the study, but none of them hadntroduction
abry disease (FD) is a result of a deﬁciency in the enzyme
lpha-galactosidase A (alpha-GLA A), which leads to the depo-
ition of globotriaosylceramide (Gb3) in the tissues.1 It is a
ereditary disease, linked to the X chromosome, that man-
fests in homozygous men  and heterozygous women, the
atter being affected to a variable degree.2 It is a disease
hat may occur in all races, whose prevalence ranges from
:50,000 in men3; however, a study conducted in newborns
ound an incidence of 1:37,000.4 FD has a broad range of clin-
cal manifestations, which makes it difﬁcult to establish a
imely diagnosis. The onset of symptoms, in general, starts
n childhood, and neuropathic pain and multiple angioker-
tomas on the skin are present in a high percentage of cases.5
n adulthood, renal impairment begins, characteristically, by
roteinuria with progression to chronic kidney disease, which
s associated with an increase in mortality, in these patients.
arapelvic cysts have also been reported in FD as a radiological
nding.6
ase  report
e  present the case of a 47-year-old man  with no family his-
ory of FD who  had been undergoing outpatient monitoring
n our department since 2002 owing to proteinuria. In 2006,
bdominal ultrasound and magnetic resonance imaging (MRI)
howed poor corticomedullary differentiation and multiple
ilateral parapelvic cysts (Figs. 1 and 2). In 2007, owing to a
eterioration in kidney function with serum creatinine levels
f 1.6 mg/dl and proteinuria levels of 1 g/24 h, it was decided
o perform an ultrasound-guided renal biopsy, which revealed
hanges consistent with moderate/severe chronic interstitial
ephritis. In 2009, the patient was admitted owing to oedema
nd dyspnoea on exertion. The examination showed no
utaneous lesions suggestive of skin angiokeratomas. Labora-
ory testing on admission showed serum creatinine levels of
.7 mg/dl and proteinuria levels of 2.4 g/24 h. Echocardiogram
nd cardiac MRI  ﬁndings showed probable myocardiopathy
ue to deposition disease (Fig. 3). Electromyography showed
igns of small ﬁbre neuropathy, with abnormalities in auto-
omic function. A sweat test was performed that collected no
weat after stimulation with pilocarpine, and an ophthalmo-
ogical study was performed that revealed cornea verticillata.
Given the clinical suspicion of FD, the level of alpha-
alactosidase activity in leukocytes and plasma was deter-
ined, using a 4-methylumbelliferyl -d-galactosidase ﬂuoro-
enic substrate. GLA activity was 0.5 nmol/h/ml (2% of normal)
n plasma, and 4.2 nmol/h/mg for protein (10.7% of normal) in(black arrows).
leukocytes, which conﬁrmed a diagnosis of FD. The enzyme’s
activity was normal in the family members of the patient who
were studied (mother and sister). A genetic study was per-
formed wherein genomic deoxyribonucleic acid (DNA) was
extracted from a dried blood spot and coding gene fragments
were ampliﬁed using PCR. Direct sequencing of the 7 exons
of the GLA gene was performed using a capillary sequencer
(ABI PRISM® 310 Genetic Analyzer). The analysis determined
that the patient was homozygous for a new c.1182del muta-Fig. 2 – Axial T1 MRI, showing kidneys with poor
corticomedullary differentiation (arrows) and parapelvic
cysts (short arrow).
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Fig. 3 – Cardiac MRI  showing diffuse thickening of both
ventricles, with lateral midwall enhancement extending to
the apex of the left ventricle, consistent with Fabry disease.
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7manifested clinical symptoms associated with the disease, to
date. The patient had a son, and so the mutation was not
transmitted to his offspring. Hormone replacement therapy
was started with agalsidase alfa (Replagal®). During follow-
up, his oedema and neuropathic pain improved, but his renal
function progressively worsened and became end-stage renal
disease, in a period of 3 years. The patient started haemodial-
ysis, and one year later, he received a living-donor kidney graft
from his wife. The patient, during post-transplant follow-up,
maintained stable renal function with an estimated glomeru-
lar ﬁltration rate of 45 ml/min/1.73 m2 and proteinuria levels
of 200 mg/24 h. He underwent follow-up biopsies at 3 months
and one year that showed no Gb3 deposits in the renal tissue.
Regarding his cardiac progression, clinically he had the onset
of dyspnoea on exertion, in addition to a worsening of his
myocardial ﬁbrosis, assessed by cardiac magnetic resonance
imaging in February 2014. It was decided to change his treat-
ment to agalsidase beta (Fabrazyme®) from then onwards.;3 6(3):310–312
Discussion
Parapelvic cysts are not uncommon in FD, but they are not spe-
ciﬁc to this condition. In a previous study of 122 FD patients (76
men  and 40 women), it was observed an increased frequency
of cortical and parapelvic cysts as compared to the general
population.6 Another study found that parapelvic renal cysts
were more  common in patients with FD than in healthy
control subjects.7 Although our patient did not show angiok-
eratomas, one of the most common clinical manifestations in
patients with FD, his signs and symptoms and the ﬁndings in
his imaging studies led us to suspect a genetic basis for the
disease. The ﬁnding of multiple cysts in the renal sinus in a
young patient with kidney failure of unknown origin should
raise the possibility of FD in the appropriate clinical context.
Conﬂicts  of  interest
The authors declare that they have no conﬂicts of interest.
 e  f  e  r  e  n  c  e  s
. Sweeley CC, Klionsky B. Fabry disease: classiﬁcation as a
sphingolipidosis and partial characterization of a novel
glycolipid. J Biol Chem. 1963;238:3148–50.
. Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M,
Feldt-Rasmussen U, et al. Females with Fabry disease
frequently have major organ involvement: lessons from the
Fabry registry. Mol Genet Metab. 2008;93:112–28.
. Clarke JT. Narrative review: Fabry disease. Ann Intern Med.
2007;146:425–33.
. Spada M, Pagliardini S, Yasuda M, Tukel T, Thiagarajan G,
Sakuraba H, et al. High incidence of later-onset Fabry disease
revealed by newborn screening. Am J Hum Genet.
2006;79:31–40.
. Hopkin RJ, Bissler J, Banikazemi M, Clarke L, Eng CM, Germain
DP,  et al. Characterization of Fabry disease in 352 pediatric
patients in the Fabry registry. Pediatr Res. 2008;64:550–5.
. Ries M, Bove Bettis K, Choyke P, Kopp J, Austin H III, Brady R,
et al. Parapelvic kidney cysts: a distinguish feature with high
prevalence in Fabry disease. Kidney Int. 2004;66:978–82.
. Glass RB, Astrin KH, Norton KI, Parsons R, Eng CM, Banikazemi
M, et al. Fabry disease: renal sonographic and magnetic
resonance imaging ﬁndings in affected males and carrier
females with the classic and cardiac variant phenotypes. J
Comput Assist Tomogr. 2004;28:158–68.
